{"id":"https://openalex.org/W7153447133","doi":"https://doi.org/10.1080/10428194.2026.2653123","title":"Effect of age and sex on cardiovascular outcomes among patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors: a propensity matched analysis","display_name":"Effect of age and sex on cardiovascular outcomes among patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors: a propensity matched analysis","publication_year":2026,"publication_date":"2026-04-11","ids":{"openalex":"https://openalex.org/W7153447133","doi":"https://doi.org/10.1080/10428194.2026.2653123","pmid":"https://pubmed.ncbi.nlm.nih.gov/41964444"},"language":"en","primary_location":{"id":"doi:10.1080/10428194.2026.2653123","doi":"https://doi.org/10.1080/10428194.2026.2653123","is_oa":true,"landing_page_url":"https://doi.org/10.1080/10428194.2026.2653123","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7153447133"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1080/10428194.2026.2653123","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102861414","display_name":"Abdulrahman Majrashi","orcid":"https://orcid.org/0000-0001-6003-9546","observed_orcids":["https://orcid.org/0000-0001-6003-9546"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]},{"id":"https://openalex.org/I4210086861","display_name":"Liverpool Heart and Chest Hospital","ror":"https://ror.org/000849h34","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800087592","https://openalex.org/I4210086861"]},{"id":"https://openalex.org/I63098007","display_name":"Liverpool John Moores University","ror":"https://ror.org/04zfme737","country_code":"GB","type":"education","lineage":["https://openalex.org/I63098007"]},{"id":"https://openalex.org/I91450128","display_name":"Jazan University","ror":"https://ror.org/02bjnq803","country_code":"SA","type":"education","lineage":["https://openalex.org/I91450128"]}],"countries":["GB","SA"],"is_corresponding":true,"raw_author_name":"Abdulrahman Majrashi","raw_affiliation_strings":["Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool","Department of Emergency Medical Services, College of Nursing & Health Sciences, Jazan University","Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool","institution_ids":["https://openalex.org/I146655781"]},{"raw_affiliation_string":"Department of Emergency Medical Services, College of Nursing & Health Sciences, Jazan University","institution_ids":["https://openalex.org/I91450128"]},{"raw_affiliation_string":"Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital","institution_ids":["https://openalex.org/I146655781","https://openalex.org/I4210086861","https://openalex.org/I63098007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086025763","display_name":"Alena Shantsila","orcid":"https://orcid.org/0000-0002-0594-8576","observed_orcids":["https://orcid.org/0000-0002-0594-8576"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]},{"id":"https://openalex.org/I4210086861","display_name":"Liverpool Heart and Chest Hospital","ror":"https://ror.org/000849h34","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800087592","https://openalex.org/I4210086861"]},{"id":"https://openalex.org/I63098007","display_name":"Liverpool John Moores University","ror":"https://ror.org/04zfme737","country_code":"GB","type":"education","lineage":["https://openalex.org/I63098007"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alena Shantsila","raw_affiliation_strings":["Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool","Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool","institution_ids":["https://openalex.org/I146655781"]},{"raw_affiliation_string":"Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital","institution_ids":["https://openalex.org/I146655781","https://openalex.org/I4210086861","https://openalex.org/I63098007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042024957","display_name":"Y G Gue","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]},{"id":"https://openalex.org/I4210086861","display_name":"Liverpool Heart and Chest Hospital","ror":"https://ror.org/000849h34","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800087592","https://openalex.org/I4210086861"]},{"id":"https://openalex.org/I63098007","display_name":"Liverpool John Moores University","ror":"https://ror.org/04zfme737","country_code":"GB","type":"education","lineage":["https://openalex.org/I63098007"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ying X. Gue","raw_affiliation_strings":["Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital","institution_ids":["https://openalex.org/I146655781","https://openalex.org/I4210086861","https://openalex.org/I63098007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108981220","display_name":"Stella Williams","orcid":"https://orcid.org/0009-0002-5202-5253","observed_orcids":["https://orcid.org/0009-0002-5202-5253"]},"institutions":[{"id":"https://openalex.org/I283776267","display_name":"Clatterbridge Cancer Centre NHS Foundation Trust","ror":"https://ror.org/05gcq4j10","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I283776267"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stella Williams","raw_affiliation_strings":["Clatterbridge Cancer Centre NHS Foundation Trust"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clatterbridge Cancer Centre NHS Foundation Trust","institution_ids":["https://openalex.org/I283776267"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038405190","display_name":"Gregory Y.H. Lip","orcid":"https://orcid.org/0000-0002-7566-1626","observed_orcids":["https://orcid.org/0000-0002-7566-1626","https://orcid.org/0000-0002-2556-2945"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]},{"id":"https://openalex.org/I4210086861","display_name":"Liverpool Heart and Chest Hospital","ror":"https://ror.org/000849h34","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800087592","https://openalex.org/I4210086861"]},{"id":"https://openalex.org/I63098007","display_name":"Liverpool John Moores University","ror":"https://ror.org/04zfme737","country_code":"GB","type":"education","lineage":["https://openalex.org/I63098007"]},{"id":"https://openalex.org/I891191580","display_name":"Aalborg University","ror":"https://ror.org/04m5j1k67","country_code":"DK","type":"education","lineage":["https://openalex.org/I891191580"]}],"countries":["DK","GB"],"is_corresponding":false,"raw_author_name":"Gregory Y. H. Lip","raw_affiliation_strings":["Danish Centre for Health Services Research, Department of Clinical Medicine, Aalborg University","Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Danish Centre for Health Services Research, Department of Clinical Medicine, Aalborg University","institution_ids":["https://openalex.org/I891191580"]},{"raw_affiliation_string":"Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital","institution_ids":["https://openalex.org/I146655781","https://openalex.org/I4210086861","https://openalex.org/I63098007"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006323887","display_name":"Andrew R. Pettitt","orcid":"https://orcid.org/0000-0002-0907-8950","observed_orcids":["https://orcid.org/0000-0002-0907-8950"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]},{"id":"https://openalex.org/I283776267","display_name":"Clatterbridge Cancer Centre NHS Foundation Trust","ror":"https://ror.org/05gcq4j10","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I283776267"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew R. Pettitt","raw_affiliation_strings":["Clatterbridge Cancer Centre NHS Foundation Trust","Department of Molecular & Clinical Cancer Medicine, University of Liverpool"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clatterbridge Cancer Centre NHS Foundation Trust","institution_ids":["https://openalex.org/I283776267"]},{"raw_affiliation_string":"Department of Molecular & Clinical Cancer Medicine, University of Liverpool","institution_ids":["https://openalex.org/I146655781"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5102861414"],"corresponding_institution_ids":["https://openalex.org/I146655781","https://openalex.org/I4210086861","https://openalex.org/I63098007","https://openalex.org/I91450128"],"apc_list":null,"apc_paid":null,"fwci":7.366,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.95019145,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":96},"biblio":{"volume":"67","issue":"8","first_page":"1696","last_page":"1706"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9819999933242798},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.9950000047683716},{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.9919999837875366},{"id":"https://openalex.org/keywords/acalabrutinib","display_name":"acalabrutinib","score":1.0},{"id":"https://openalex.org/keywords/atrial-fibrillation","display_name":"atrial fibrillation","score":0.9990000128746033},{"id":"https://openalex.org/keywords/age","display_name":"age","score":0.5329999923706055},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.9879999756813049},{"id":"https://openalex.org/keywords/cardiovascular-outcomes","display_name":"cardiovascular outcomes","score":0.7350000143051147},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.39500001072883606},{"id":"https://openalex.org/keywords/cardiovascular-risk-assessment","display_name":"cardiovascular risk assessment","score":0.3569999933242798}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8205999732017517},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.6945000290870667},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6381000280380249},{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.5875999927520752},{"id":"https://openalex.org/C17923572","wikidata":"https://www.wikidata.org/wiki/Q7250160","display_name":"Propensity score matching","level":2,"score":0.5871999859809875},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.44209998846054077},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.43799999356269836},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3222000002861023},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.3073999881744385},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.288100004196167},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.2856999933719635},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2777999937534332},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.2574999928474426},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.25099998712539673}],"mesh":[{"descriptor_ui":"D000077329","descriptor_name":"Agammaglobulinaemia Tyrosine Kinase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012737","descriptor_name":"Sex Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057216","descriptor_name":"Propensity Score","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1080/10428194.2026.2653123","doi":"https://doi.org/10.1080/10428194.2026.2653123","is_oa":true,"landing_page_url":"https://doi.org/10.1080/10428194.2026.2653123","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},{"id":"pmid:41964444","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41964444","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & lymphoma","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire/bc24cdad-9c01-46cf-ae52-3608ebda0cce","doi":null,"is_oa":true,"landing_page_url":"https://vbn.aau.dk/da/publications/bc24cdad-9c01-46cf-ae52-3608ebda0cce","pdf_url":null,"source":{"id":"https://openalex.org/S4306401731","display_name":"VBN Forskningsportal (Aalborg Universitet)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I891191580","host_organization_name":"Aalborg University","host_organization_lineage":["https://openalex.org/I891191580"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Majrashi, A, Shantsila, A, Gue, Y X, Williams, S, Lip, G Y H & Pettitt, A R 2026, 'Effect of age and sex on cardiovascular outcomes among patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors : a propensity matched analysis', Leukemia and Lymphoma, vol. 67, no. 8, pp. 1696-1706. https://doi.org/10.1080/10428194.2026.2653123","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1080/10428194.2026.2653123","doi":"https://doi.org/10.1080/10428194.2026.2653123","is_oa":true,"landing_page_url":"https://doi.org/10.1080/10428194.2026.2653123","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320311223","display_name":"Jazan University","ror":"https://ror.org/02bjnq803"},{"id":"https://openalex.org/F4320320323","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W1979837915","https://openalex.org/W2076804009","https://openalex.org/W2121913400","https://openalex.org/W2142514031","https://openalex.org/W2204986825","https://openalex.org/W2316021978","https://openalex.org/W2493501265","https://openalex.org/W2525969549","https://openalex.org/W2561449166","https://openalex.org/W2739393823","https://openalex.org/W2757527323","https://openalex.org/W2900742318","https://openalex.org/W2914358799","https://openalex.org/W2915082572","https://openalex.org/W2973195462","https://openalex.org/W2978550355","https://openalex.org/W2980937306","https://openalex.org/W3094484041","https://openalex.org/W3185756680","https://openalex.org/W3212872241","https://openalex.org/W4200375829","https://openalex.org/W4213170825","https://openalex.org/W4283824369","https://openalex.org/W4298088050","https://openalex.org/W4319319397","https://openalex.org/W4366251720","https://openalex.org/W4376110980","https://openalex.org/W4387710268","https://openalex.org/W4410267967","https://openalex.org/W4410411876","https://openalex.org/W4410706937","https://openalex.org/W4417198783"],"related_works":["https://openalex.org/W4405048528","https://openalex.org/W7169781252","https://openalex.org/W4405037561","https://openalex.org/W4403812927","https://openalex.org/W4308773243","https://openalex.org/W4401668696","https://openalex.org/W7128973486","https://openalex.org/W6982320791","https://openalex.org/W7165641894","https://openalex.org/W4408149519"],"abstract_inverted_index":{"The":[0,105],"combined":[1],"effect":[2],"of":[3,10,42,69,107],"age":[4,74,114],"and":[5,44,75,115,150],"sex":[6],"on":[7],"the":[8,35,65],"risk":[9,106],"atrial":[11],"fibrillation":[12],"(AF)":[13],"in":[14,79,88,100],"patients":[15,142],"receiving":[16],"Bruton":[17],"tyrosine":[18],"kinase":[19],"inhibitors":[20],"(BTKi)":[21],"is":[22],"unclear.":[23],"To":[24],"address":[25],"this":[26,124],"knowledge":[27],"gap,":[28],"propensity":[29],"score":[30],"matching":[31],"was":[32],"applied":[33],"to":[34,38,82,123,127,134],"TriNetX":[36],"database":[37],"generate":[39],"matched":[40],"cohorts":[41],"males":[43,80,90,119],"females":[45,102],"with":[46,73,96,109,113,117],"chronic":[47],"lymphocytic":[48],"leukemia":[49],"(CLL)":[50],"who":[51],"received":[52],"ibrutinib":[53],"(n":[54,59],"=":[55,60],"5312)":[56],"or":[57],"acalabrutinib":[58,110],"3110).":[61],"AF":[62,94,108],"events":[63],"during":[64,151],"first":[66],"three":[67,89],"years":[68],"BTKi":[70],"therapy":[71,138],"increased":[72],"were":[76],"more":[77,121],"common":[78],"compared":[81,95,126],"females.":[83,129],"For":[84],"ibrutinib,":[85],"nearly":[86],"one":[87,99],"aged":[91,103],"\u226575":[92],"developed":[93],"fewer":[97],"than":[98],"ten":[101],"18\u201374.":[104],"also":[111],"varied":[112],"sex,":[116],"older":[118],"appearing":[120],"vulnerable":[122],"complication":[125],"younger":[128],"These":[130],"findings":[131],"are":[132],"relevant":[133],"decision-making":[135],"about":[136],"CLL":[137],"options":[139],"and,":[140],"for":[141],"commencing":[143],"BTKi,":[144],"determining":[145],"appropriate":[146],"cardiovascular":[147],"assessments":[148],"before":[149],"therapy.":[152]},"counts_by_year":[{"year":2026,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-04-12T00:00:00"}